Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Anticancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10769640
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The gastrointestinal polyamine source depletion enhances DFMO induced polyamine depletion in MCF-7 human breast cancer cells in vivo.

  1998cited by this paper
• Polyamine deprivation prevents the development of tumour-induced immune suppression.

  1997cited by this paper
• Acquired tamoxifen resistance in human breast cancer--potential mechanisms and clinical implications.

  1997cited by this paper
• Involvement of the polyamine pathway in breast cancer progression.

  1995cited by this paper
• Exploration of the Therapeutic Potential of the Antiestrogen RU 58668 in Breast Cancer Treatment

  1995cited by this paper
• Polyamine deprivation enhances antitumoral efficacy of chemotherapy.

  1992cited by this paper
• Response after withdrawal of tamoxifen and progestogens in advanced breast cancer.

  1992cited by this paper
• Role of polyamines in the growth of hormone-responsive and -resistant human breast cancer cells in nude mice.

  1992cited by this paper
• Inhibition of the growth of U-251 human glioblastoma in nude mice by polyamine deprivation.

  1991cited by this paper
• Variations in amplification and expression of the ornithine decarboxylase gene in human breast cancer cells

  1991cited by this paper
• Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenografts.

  1991cited by this paper
• Endogenous and exogenous polyamines in support of tumor growth.

  1990cited by this paper
• Polyamine involvement in the growth of hormone-responsive and -resistant human breast cancer cells in culture.

  1989cited by this paper
• The gastrointestinal tract as polyamine source for tumor growth.

  1989cited by this paper
• Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration.

  1988cited by this paper
• Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy.

  1988cited by this paper
• An evaluation of the involvement of polyamines in modulating MCF-7 human breast cancer cell proliferation and progesterone receptor levels by estrogen and antiestrogen.

  1987cited by this paper
• Role of polyamines in estradiol-induced growth of human breast cancer cells.

  1985cited by this paper
• Red blood cell polyamines in mice bearing the lewis lung carcinoma (3ll) and in patients with bronchopulmonary cancers

  1984cited by this paper
• Effects of alpha-difluoromethylornithine alone and combined with adriamycin or vindesine on L1210 leukemia in mice, EMT6 solid tumors in mice, and solid tumors induced by injection of hepatoma tissue culture cells in rats.

  1981cited by this paper
• Polyamines in rapid growth and cancer.

  1978cited by this paper

• Polyamines metabolism and breast cancer: state of the art and perspectives

  2014influential citation
• A potential estrogen mimetic effect of a bis(ethyl)polyamine analogue on estrogen receptor positive MCF-7 breast cancer cells

  2011cites this paper
• Polyamines et cancer : bases scientifiques et potentialités thérapeutiques

  2010cites this paper
• Molecular aspects of antiestrogen resistance and autophagy in breast cancer cells

  2009cites this paper
• Lipophilic lysine-spermine conjugates are potent polyamine transport inhibitors for use in combination with a polyamine biosynthesis inhibitor.

  2009cites this paper
• Effect of difluoromethylornithine on thyroid function in rats.

  2009cites this paper
• Increased blood spermine levels decrease the cytotoxic activity of lymphokine-activated killer cells: a novel mechanism of cancer evasion

  2007cites this paper
• Histone H1 inhibits the proliferation of MCF 7 and MDA MB 231 human breast cancer cells

  2006cites this paper
• Clinical Approaches to Discovering and Testing New Breast Cancer Prevention Drugs

  2005cites this paper
• Protein biomarkers for breast cancer prevention.

  2004cites this paper
• Novel Agents for Chemoprevention, Screening Methods, and Sampling Issues

  2004cites this paper
• Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitors.

  2003cites this paper
• Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice.

  2003cites this paper
• Analysis of polyamines as markers of (patho)physiological conditions.

  2002cites this paper
• Development of polyamine analogs as cancer therapeutic agents.

  2002cites this paper
• Breast cancer chemoprevention: current challenges and a look toward the future.

  2002cites this paper
• Breast cancer chemoprevention: beyond tamoxifen

  2001cites this paper
• Breast cancer prevention: present and future.

  2001cites this paper
• Beyond Tamoxifen

  2001cites this paper